Fadil Mohamed, Essaber Hatim, Bakkari Asaad El, Jerguigue Hounayda, Amalik Sanae, Omor Youssef, Latib Rachida
Radiology department, National Oncology Institute, University Hospital Center Ibn Sina, Rabat, Morocco.
Radiol Case Rep. 2025 Mar 15;20(6):2768-2771. doi: 10.1016/j.radcr.2025.02.068. eCollection 2025 Jun.
Carcinomas often metastasize to distant organs by detaching from the primary tumor and entering the bloodstream. These circulating tumor cells are transported to sites such as lung capillaries and subsequently disseminated through systemic circulation. However, hepatocellular carcinoma (HCC) rarely metastasizes to distant organs, even in advanced stages. Instead, HCC frequently leads to intravascular and intrahepatic parenchymal metastases. Portal vein thrombosis (PVT), present in 10%-40% of HCC patients at diagnosis and 35%-44% at death or liver transplant, is a significant prognostic marker, associated with worse outcomes and reduced survival. Patients with PVT demonstrate markedly shorter overall survival compared to those without PVT, with main portal vein thrombosis indicating the poorest prognosis. Here, we report an unusual case of an enormous portal metastasis from liver HCC, characterized by a ``vessel-inside-vessel'' appearance.
癌瘤常常通过与原发肿瘤分离并进入血液循环,转移至远处器官。这些循环肿瘤细胞被输送至肺毛细血管等部位,随后通过体循环扩散。然而,肝细胞癌(HCC)即便在晚期也很少转移至远处器官。相反,HCC常常导致血管内和肝实质内转移。门静脉血栓形成(PVT)在HCC患者诊断时的发生率为10%-40%,在死亡或肝移植时为35%-44%,是一个重要的预后指标,与较差的预后和缩短的生存期相关。与无PVT的患者相比,PVT患者的总生存期明显更短,主要门静脉血栓形成提示预后最差。在此,我们报告一例罕见的肝脏HCC巨大门静脉转移病例,其特征为“血管套血管”表现。